Synthesis of Isotopically Labeled Fusarium Mycotoxin ¹³C2-Moniliformin [1-Hydroxycyclobut-1-ene-3,4-dione]

Lilia Lohrey; Takeshi Murata; Daisuke Uemura; Hans-Ulrich Humpf

doi:10.1055/s-0030-1261189

LETTER

Synthesis of Isotopically Labeled Fusarium Mycotoxin ^¹³C₂-Moniliformin [1-Hydroxycyclobut-1-ene-3,4-dione]

Lilia Lohrey^a, Takeshi Murata^b, Daisuke Uemura^b,c, Hans-Ulrich Humpf*^a
^a Institut für Lebensmittelchemie, Westfälische Wilhelms-Universität Münster, Corrensstr. 45, 48149 Münster, Germany
Fax: +49(251)8333396; e-Mail: humpf@uni-muenster.de;
^b Department of Chemistry, Graduate School of Science, , Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8602, Japan
^c Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi,Yokohama 223-8655, Japan

Abstract

All articles of this category

Abstract

The total synthesis of isotopically labeled [^¹³C₂]-1-hydroxycyclobut-1-ene-3,4-dione (moniliformin) a fungal toxic secondary metabolite to be used as internal standard for mycotoxin analysis is described. The synthesis proceeds in four steps starting from 1,4-dioxane, which was converted to 2,3-dihydro-1,4-dioxine followed by a [2+2]-cycloaddition with trichloroacetyl chloride-1,2-^¹³C₂ as ^¹³C source. The ^¹³C₂-labeled cyclobutanone precursor was transformed to [^¹³C₂]-moniliformin by acid-catalyzed hydrolysis. The successful incorporation of two ^¹³C atoms was proven by detailed NMR and mass spectrometric studies of labeled moniliformin and its precursor.

Key words

Fusarium - moniliformin - [2+2] cycloaddition - stable isotope dilution analysis - HPLC-MS/MS

Full Text

References

References and Notes

1 Sharman M. Gilbert J. Chelkowski J. Food Addit. Contam. 1991, 8: 459

2 Schütt F. Nirenberg H. Demi G. Mycotox. Res. 1998, 14: 35

3 Springer JP. Clardy J. Cole RJ. Kirksey JW. Hill RK. Carlson RM. Isidor JL. J. Am. Chem. Soc. 1974, 96: 2267

4 Cole R. Kirksey JW. Cutler HG. Doupnik BL. Peckham JC. Science 1973, 179: 1324

5 Nagaraj RY. Wu W. Will JA. Vesonder RF. Avian Dis. 1996, 40: 223

6 Ledoux DR. Bermudez AJ. Rottinghaus GE. Broomhead J. Bennett GA. Poultry Sci. 1995, 74: 297

7 Thiel PG. Biochem. Pharmacol. 1978, 27: 483

8 Tang L. Kebarle P. Anal. Chem. 1993, 65: 3654

9 Webb KS. Carter D. Rapid Commun. Mass Spectrom. 1997, 11: 155

10 Bellus D. Fischer H. Greuter H. Martin P. Helv. Chim. Acta 1978, 61: 1784

11 Fétizon M. Hanna I. Synthesis 1990, 583

12 Scharf HD. Frauenrath H. Pinske W. Chem. Ber. 1978, 111: 168

13 Mitchell J. Perkins M. Gilbert J. Mycotox. Res. 1985, 1: 83

14 Summerbell RK. Bauer LN. J. Am. Chem. Soc. 1935, 57: 2364

15 Moss RD. Paige JN. J. Chem. Eng. Data 1967, 12: 452

16 Shinohara N, Takahashi M, and Igarashi M. inventors; JP 10067773.

17

Compound 3 never distilled over separately neither at atmospheric nor at reduced pressure. Distillation was only possible as azeotropic mixture after the addition of H₂O.

18

Purification by continuous liquid-liquid extraction with Et₂O did not give moniliformin in sufficiently pure grade (NMR).

Supplementary Material

Supporting Information